Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection

E. Gupta et al. Journal of Clinical Virology 88 (2017) 46–51 (2019)

Molecular testing atthe point-of-care may turn outto be game changer for HCVdiagnosis and treatment monitoring, through increased sensitivity, reduced turnaround time, and ease of performance. One such assay GeneXpert® has recently been released. Comparative analysis between performances of GeneXpert® and Abbott HCV-RNA was done

Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection

Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection (191)

PDF
English
In partnership with:
ISFF
FUAS
Correlation Network